WallStreetZenWallStreetZen

NASDAQ: VERA
Vera Therapeutics Inc Stock

$38.00-0.43 (-1.12%)
Updated Jun 12, 2024
VERA Price
$38.00
Fair Value Price
-$0.19
Market Cap
$2.08B
52 Week Low
$9.24
52 Week High
$50.78
P/E
-18.54x
P/B
5.88x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$94.30M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.19
Operating Cash Flow
-$100M
Beta
1.08
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

VERA Overview

Vera Therapeutics, Incorporated develops treatments for patients with serious immunological diseases in the U.S. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. Known as Trucode Gene Repair, Inc. until 2020, Vera Therapeutics was incorporated in 2016 and is headquartered in Brisbane, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VERA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VERA ($38.00) is overvalued by 20,317.62% relative to our estimate of its Fair Value price of -$0.19 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
VERA ($38.00) is not significantly undervalued (20,317.62%) relative to our estimate of its Fair Value price of -$0.19 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
VERA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VERA due diligence checks available for Premium users.

Be the first to know about important VERA news, forecast changes, insider trades & much more!

VERA News

Valuation

VERA fair value

Fair Value of VERA stock based on Discounted Cash Flow (DCF)
Price
$38.00
Fair Value
-$0.19
Undervalued by
20,317.62%
VERA ($38.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VERA ($38.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VERA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VERA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-18.54x
Industry
-9.14x
Market
30.03x

VERA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.88x
Industry
6.31x
VERA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VERA's financial health

Profit margin

Revenue
$0.0
Net Income
-$28.4M
Profit Margin
0%
VERA's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$419.4M
Liabilities
$65.8M
Debt to equity
0.19
VERA's short-term assets ($416.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VERA's short-term assets ($416.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VERA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$33.8M
Investing
-$219.3M
Financing
$276.5M
VERA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VERA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VERA$2.08B-1.12%-18.54x5.88x
RCKT$2.06B-0.79%-7.98x4.67x
VCEL$2.12B+0.48%N/A9.04x
KYMR$2.12B+0.09%-13.78x2.99x
IMCR$2.03B-1.39%-33.92x5.64x

Vera Therapeutics Stock FAQ

What is Vera Therapeutics's quote symbol?

(NASDAQ: VERA) Vera Therapeutics trades on the NASDAQ under the ticker symbol VERA. Vera Therapeutics stock quotes can also be displayed as NASDAQ: VERA.

If you're new to stock investing, here's how to buy Vera Therapeutics stock.

What is the 52 week high and low for Vera Therapeutics (NASDAQ: VERA)?

(NASDAQ: VERA) Vera Therapeutics's 52-week high was $50.78, and its 52-week low was $9.24. It is currently -25.17% from its 52-week high and 311.26% from its 52-week low.

How much is Vera Therapeutics stock worth today?

(NASDAQ: VERA) Vera Therapeutics currently has 54,701,217 outstanding shares. With Vera Therapeutics stock trading at $38.00 per share, the total value of Vera Therapeutics stock (market capitalization) is $2.08B.

Vera Therapeutics stock was originally listed at a price of $11.50 in May 14, 2021. If you had invested in Vera Therapeutics stock at $11.50, your return over the last 3 years would have been 230.43%, for an annualized return of 48.95% (not including any dividends or dividend reinvestments).

How much is Vera Therapeutics's stock price per share?

(NASDAQ: VERA) Vera Therapeutics stock price per share is $38.00 today (as of Jun 12, 2024).

What is Vera Therapeutics's Market Cap?

(NASDAQ: VERA) Vera Therapeutics's market cap is $2.08B, as of Jun 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vera Therapeutics's market cap is calculated by multiplying VERA's current stock price of $38.00 by VERA's total outstanding shares of 54,701,217.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.